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Abstract
Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide. Increasing age has been associated with
elevated circulating levels of pro-inﬂammatory mediators. We aimed to determine the impact of ageing on the systemic inﬂammatory
response to CAP. In total 201 CAP patients were enrolled. Blood samples were obtained upon presentation, and on days 2, 3 and 5. For the
current analysis patients ≤50 and ≥80 years were included. The Pneumonia Severity Index (PSI) score was calculated at presentation. The
study encompassed 46 CAP patients aged ≤50 years (median 37 years) and 41 CAP patients aged ≥80 years (median 84 years). In both
groups Streptococcus pneumoniae was the common causative microorganism. Whereas most young patients had a PSI score of I (54%), 98%
of elderly patients had a PSI score ≥III (p <0.001). Four elderly patients died vs. none of the young patients (p 0.045). Older patients
demonstrated lower serum C-reactive protein levels on admission and during the course of their hospitalization (p 0.001) in spite of more
severe disease. Serum concentrations of pro-inﬂammatory (interleukin (IL)-6 and IL-8) and anti-inﬂammatory cytokines (IL-10 and IL-1
receptor antagonist) did not differ between age groups, although admission IL-8 levels tended to be higher in elderly patients (p 0.05).
Cytokine levels were positively correlated with PSI in young but not in elderly patients. These results suggest that elderly patients show an
absolute (C-reactive protein) or relative (cytokines) reduction in their systemic inﬂammatory response on admission for CAP.
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Introduction
Community acquired pneumonia (CAP) is a leading cause of
morbidity and mortality worldwide [1]. It is one of the most
common infectious diseases requiring hospitalization and has
an overall mortality of more than 3 million deaths yearly
worldwide [2]. The incidence of CAP increases dramatically
with high age and elderly people account for the majority of
CAP-related hospital admissions [3]; more than 60% of all CAP
cases occur among those aged ≥65 years of age [4]. In older
adults, CAP is a potentially life threatening disease with an
increased risk of severe sepsis and a more than doubled
mortality rate [5]. More than one-third of all sepsis cases in
elderly patients are due to pneumonia and the relative risk of
sepsis is 13 times higher for those aged 65 or above [6]. Also,
after hospital discharge the threat of mortality remains and
almost half of all elderly patients surviving hospitalization for
CAP die in the subsequent year [7]. Although older age is
associated with increasing co-morbidity, institutionalization
and underlying disease processes, this does not fully explain
the higher disease burden and increased hospital and long-
term mortality caused by infections such as CAP [7–9].
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Ageing has been related to sustained low-grade inﬂamma-
tion, a process referred to as inﬂamm-ageing [10,11]. It has
been suggested that inﬂamm-ageing can blunt acute immune
responses and increase the susceptibility to infectious
diseases [12].
In this study we aimed to determine differences in
inﬂammatory responses between young and old individuals
during the ﬁrst days after admission to the hospital for
CAP. Considering that cytokines have short half-lives in the
circulation and as a consequence provide only temporary
information on the systemic inﬂammatory response [13], we
also included C-reactive protein (CRP) levels in our analysis.
Methods
Inclusion criteria
This prospective study included all patients aged 18 years and
over with conﬁrmed pneumonia admitted to the emergency
department of the St Antonius Hospital (Nieuwegein, the
Netherlands) from October 2004 until August 2006 [14].
Pneumonia was deﬁned as new inﬁltrate on chest X-ray and
at least two out of six of the following common clinical
symptoms of pneumonia: cough, production of sputum,
auscultatory ﬁndings concordant with pneumonia, tempera-
ture >38 or <35°C, CRP elevated three times above normal
(>15 mg/L) or leukocytosis or leukopenia deﬁned as white
blood count >10 9 109/L, <4 9 109/L or >10% rods in
leukocyte differentiation. Patients with a recent hospitalization
(<30 days) or deﬁned immunodeﬁciency (congenital or
acquired, including prednisone or its equivalent >20 mg/day
for more than three consecutive days or chemotherapy within
the last 6 weeks) or haematological malignancies were
excluded from participation. For each patient the Pneumonia
Severity Index (PSI) [15] was calculated and clinical and
laboratory parameters were recorded at inclusion. Blood was
collected and processed for storage of serum samples. Medical
history, causative organism, length of hospital stay, intensive
care admission and mortality were assessed. The medical
ethical committee approved the study and written informed
consent was obtained in the emergency department from all
participating patients.
Assays
Blood samples were collected from every individual at
presentation (day 1). Consecutive samples were drawn at 8
am on days 2, 3 and 5. Serum was separated by centrifugation
and stored at 80°C. Systemic circulating concentrations of
IL-6, IL-8, IL-10 and IL-1 receptor antagonist (IL-1RA) were
measured with a multiplex immunoassay kit from Biorad
Laboratories (Hercules, CA, USA). CRP was measured using
equipment from Roche Diagnostics (Mannheim, Germany).
Pathogen identiﬁcation
At presentation to the emergency room two samples of
peripheral blood cultures were taken. Blood cultures were
regarded positive when a respiratory pathogen was cultured.
Sputum cultures were taken at presentation or within 24 h
after admission. Sputum cultures were only used for further
analysis when containing less than 25 epithelial cells per view in
the absence of leukocytes, or <50 epithelial cells per view
when leukocytes were present. When multiple microorgan-
isms were found, the microorganism with the most abundant
growth was considered the causative pathogen. Microorgan-
isms causing atypical pneumonia, Mycoplasma pneumoniae,
Legionella pneumophila and Chlamydophila pneumoniae and
psittaci, were detected using polymerase chain reactions
(PCRs) for detection of microbial DNA in sputum. Antigen
testing was carried out in urine samples for Streptococcus
pneumoniae and L. pneumophila at admission or within the ﬁrst
24 h. Mycoplasma pneumoniae, Coxiella burnetti or respiratory
viruses (inﬂuenza A and B, parainﬂuenza viruses, adenovirus
and respiratory syncytial virus) were detected using serological
testing for the presence of antibodies. Only samples with a
fourfold rise in antibody titres were considered positive. Viral
culture for inﬂuenza viruses was carried out on pharyngeal
swab samples. Pneumonia was deﬁned as being of viral origin
when a positive viral test was combined with negative cultures
and negative antigen testing for bacterial pathogens.
Statistical analysis
All statistical tests were carried out using IBM SPSS version 19,
taking into account a two-tailed p-value of <0.05. The
difference between binary categorical data was assessed using
a chi-square test or a Fisher’s exact test when appropriate. All
cytokine data were tested for normal distribution using Q-Q
plots and histograms. Continuous, non-parametrical data were
analyzed using a Mann–Whitney U-test. For longitudinal
analyses over time, a regression analysis with mixed models,
to account for correlation of the markers over time, was used.
Correlations were tested using a Spearman rho test.
Results
Demographics, co-morbidities and severity of disease
A total of 201 patients were included in the study [14]. For the
current analysis only a subset of patients from this previously
published cohort aged ≤50 years (N = 46) and aged ≥80 years
(N = 41) were analyzed. Baseline characteristics of these
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patients are shown in Table 1. Men and women were equally
distributed among young and elderly patients. As expected,
elderly patients had more co-morbidities, in particular COPD
(49% in the elderly vs. none in the young group, p <0.001). Use
of antibiotics prior to presentation to the emergency depart-
ment was equally distributed between the two groups. With
regard to disease severity, the PSI was signiﬁcantly higher in
elderly patients (p <0.001), and elderly patients were in a
higher PSI Fine class compared with young patients (p <0.001).
Because the PSI Fine class differentiation contains age as a
variable factor, a modiﬁed PSI Fine score was calculated leaving
age out. This modiﬁed PSI Fine score was not signiﬁcantly
different between the two groups (p 0.132). Older patients
had a longer length of stay in the hospital (median 14 days vs.
8 days for young patients, p <0.001), while the intensive care
admission rate was similar in both groups. Mortality was higher
in elderly patients; four elderly patients died (10%) compared
with none of the young patients (p 0.045).
Causative organisms
Table 2 shows the distribution of causative organisms in both
groups. The causative microorganism could be identiﬁed for
76% of the young group and 56% of the elderly group
(p <0.05). For both groups S. pneumoniae was the most
common causative microorganism (35% in young patients
and 22% in elderly patients). There was no signiﬁcant
difference between the two groups with regard to causative
pathogens, except for atypical pathogens (in particular
M. pneumoniae), which were not documented in elderly
patients (15% vs. 0%, p 0.035).
Levels of inﬂammatory markers
Admission blood was obtained for determination of CRP from
all patients (N = 87). For the assessment of IL-6, IL-8, IL-10
and IL-1RA levels, blood was obtained from 80% of young
patients (N = 37) and 80% of the elderly patients (N = 33),
gradually diminishing following the duration of admission
(indicated in Fig. 1). Elderly patients showed overall signiﬁ-
cantly lower serum CRP during the course of their disease
compared with young patients (Fig. 1a, p 0.001). The differ-
ence was most discriminative at admission (p <0.001). In
contrast, the serum concentration of IL-6, which is considered
a main driver of the acute phase protein response, did not
differ between elderly and young patients (Fig. 1b). Serum IL-8
levels were higher in elderly patients on admission (p 0.05 vs.
young patients); although mean IL-8 concentrations remained
higher in older patients on subsequent days, the difference
with young patients was not signiﬁcant (Fig. 1c, p 0.24). Serum
levels of the anti-inﬂammatory cytokines IL-10 (Fig. 1d) and
IL-1RA (Fig. 1e) did not differ between groups.
To determine whether serum CRP and cytokine levels
correlated with severity of disease in the two age groups, we
calculated Spearman’s correlation coefﬁcients of the concen-
trations of these inﬂammation markers with the PSI score, as
well as with the modiﬁed PSI score (i.e. leaving the age factor
TABLE 1. General characteristics of patients with commu-
nity-acquired pneumonia in young (≤50 years) and elderly
patients (≥80 years)
Age
≤50 years
Age
≥80 years
p valueN (%) N (%)
Total 46 41
Male, n (%) 28 (61) 20 (49) 0.258
Age, mean (SD) 37 (7) 84 (4)
Living arrangement
Home 46 (100) 38 (93) 0.101
Nursing facility – 3 (8)
Medical history
COPD – 20 (49) <0.001
Asthma 5 (10) – 0.057
Local solid tumor – 5 (12) 0.015
Diabetes type II
oral treatment
– 5 (12) 0.020
Diabetes type II
insulin
– 6 (15) 0.009
Hypercholesterolaemia – 3 (7) 0.101
CVA – 5 (12) 0.020
Hypertension – 12 (29) <0.001
PVD – 5 (12) 0.020
Pre-hospital antibiotic
therapy
16 (35) 8 (20) 0.145
PSI mean (SD) 51 (21) 108 (30) <0.001
PSI Fine class
Low I 25 (54) – <0.001
Low II 14 (30) 1 (2)
Low III 5 (11) 15 (37)
Moderate IV 2 (4) 12 (29)
High V – 13 (32)
Modiﬁed PSI Fine score
(mean  SD)
18 (17) 29 (29) 0.132
Length of stay, (days)
median (IQR)
8 (7–14) 14 (10–22) <0.001
ICU admission (%) 4 (9) 2 (5) 0.680
Death – 4 (10) 0.045
Bold value indicates signiﬁcance.
COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident
(stroke); PVD, peripheral vascular disease; PSI, pneumonia severity index; ICU,
intensive care unit.
TABLE 2. Causative microorganism
Age
≤50 years
Age
≥80 years
p valueN (%) N (%)
No microorganism cultured 11 (24) 18 (44) 0.048
Gram positive 19 (41) 11 (27) 0.156
Streptococcus pneumoniae 16 (35) 9 (22) 0.620
Staphylococcus aureus 2 (4) 2 (5) 1.000
Other gram-positive bacteriaa 1 (2) – 1.000
Gram negative 3 (7) 6 (15) 0.215
Haemophilus inﬂuenza 1 (2) 4 (10) 1.000
Klebsiella pneumoniae – 2 (5) 0.750
Pseudomonas aeruginosa 1 (2) – 1.000
Other gram-negative bacteriab 1 (2) – 1.000
Atypical 11 (24) 2 (5) 0.042
Mycoplasma pneumoniae 7 (15) – 0.035
Legionella pneumophila 2 (4) 2 (5) 1.000
Other atypical bacteriac 2 (4) – 0.042
Viral 2 (4) 4 (10) 0.415
Bold value indicates signiﬁcant values.
aNon-pneumococcal Streptococci
bAcinetobacter calcoaceticus, Stenotrophomionas maltophilia.
cChlamydophila pneumoniae/psittaci, Coxiella burnetti.
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out), on admission (Table 3). In young patients, admission IL-6,
IL-8, IL-10 and IL-1RA positively correlated with the modiﬁed
PSI score; correlations remained signiﬁcant for IL-6 and IL-10
upon analysis of the unmodiﬁed PSI score. In contrast,
admission cytokine concentrations did not correlate with
either modiﬁed or unmodiﬁed PSI scores in elderly patients.
Serum CRP did not correlate with (modiﬁed) PSI scores in
either age group.
Discussion
This study describes differences in the systemic inﬂammatory
response between young (≤50 years) and elderly patients
(≥80 years) with CAP. The major ﬁnding of this study is that
older patients had lower CRP levels on admission and the days
thereafter, while cytokine concentrations showed marginal
differences between age groups, approaching signiﬁcance only
for admission IL-8.
Old age is associated with chronic elevation of pro-
inﬂammatory cytokines and CRP, a condition that has been
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FIG. 1. Levels of inﬂammatory markers.
Median values and standard error of the
median. Pa = Mann‒Whitney U-test day 1.
Pb = longitudinal analysis over time using
mixed models a, CRP; b, IL-6; c, IL-8; d,
IL-10; e, IL1RA.
TABLE 3. Correlation between CRP and cytokine levels and
Pneumonia Severity Index (PSI) on admission stratiﬁed
according to age group
Age group Cytokine PSI
Modiﬁed
PSI
Age ≤50 years CRP r 0.13 0.20
IL-6 r 0.40* 0.43**
IL-8 r 0.31 0.40*
IL-10 r 0.52** 0.57**
IL-1RA r 0.32 0.34*
Age ≥80 years CRP r 0.22 0.26
IL-6 r 0.11 0.00
IL-8 r 0.17 0.08
IL-10 r 0.04 0.04
IL-1RA r 0.14 0.05
Bold value indicates signiﬁcance.
Modiﬁed PSI males = PSI – age; modiﬁed PSI females = PSI  (age10).
*p value <0.05.
**p value <0.01.
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referred to as inﬂamm-ageing [11]. It has been postulated that
in ageing individuals cellular damage and reactivation of latent
viral infections (such as cytomegalovirus) chronically stimulate
innate immune cells, resulting in a sustained pro-inﬂammatory
state [16]. Such a pro-inﬂammatory background can alter the
responsiveness to pathogens, leading to failure in the conse-
quential immune response [16]. The declined ability of elderly
patients to react properly upon infection, to initiate and
maintain an adequate protective immune response and to
develop immunological memory has been described as immu-
nosenescence [17]. In this context a lower immunological
response is to be expected in ageing individuals. However, we
did not ﬁnd signiﬁcant differences in the serum concentrations
of the pro-inﬂammatory cytokines IL-6 and IL-8, or the
anti-inﬂammatory cytokines IL-10 and IL-1RA, between young
and elderly patients with CAP. In accordance, a recently
conducted observational study showed a similar cytokine
response between young and older CAP patients, measured by
the serum levels of TNF, IL-6 and IL-10 [18]. Disease severity
and 90-day mortality were higher in older patients in this
study, suggesting a relatively attenuated cytokine response in
this age group [18].
A recent literature review supports the hypothesis of
chronic baseline inﬂammation in elderly people and highlights
the scarce research into cytokine responses to infection in this
speciﬁc patient group [19]. Another investigation also showed
no differences in circulating IL-6 and IL-10 concentrations in
CAP patients of different age groups, although the disease
severity, measured with PSI and CURB score, was signiﬁcantly
higher in elderly patients [20]. In our study, elderly patients
also presented with more severe disease, as reﬂected by a
signiﬁcantly longer hospital stay, higher mortality and higher
severity of disease markers such as Fine class and PSI score,
but indeed failed to show persistent inﬂammatory parameters
during hospital admission matching these observations. Nota-
bly, serum cytokine concentrations were positively correlated
with the PSI score only in young patients, whereas such
correlations were not found in elderly patients, further
suggesting that the systemic cytokine response during CAP
does not reﬂect the severity of disease in old age. Alterna-
tively, the PSI score may less accurately reﬂect CAP severity in
very old patients. Our results are supported by a study
conducted in the ICU, reporting no differences in a large set of
cytokines and chemokines between older and younger patients
with septic shock at admission [21].
The fact that old patients demonstrated cytokine levels that
were similar to those measured in young patients in spite of
more severe disease suggests that ageing is associated with a
reduced capacity to produce cytokines upon acute infection.
Several studies have provided insight into why older individuals
might respond less avidly to infection than young persons.
Multiple key players of the immune system have been shown
to develop age-related defects. Dendritic cells, important for
innate and adaptive immunity, have an impaired ability to
produce pro-inﬂammatory cytokines such as IL-6 and IL-12
upon Toll-like receptor engagement in ageing individuals
[22,23], and peripheral blood monocytes from older persons
show an impaired cytokine response upon in vitro stimulation
with lipopolysaccharide [24]. These ﬁndings are in line with
reports of diminished phagocytizing capacity of dendritic cells
[25], monocytes [10] and neutrophils [26] from older individ-
uals, suggesting an age-related dysregulation in the function of
innate immune cells.
The most notable ﬁnding was the overall lower serum CRP
levels, both on admission and subsequent days, in old patients
with CAP. CRP is a typical acute phase protein that is mainly
produced by the liver upon IL-6 stimulation. In our population,
this decreased CRP response, however, cannot be pinned on
an overall reduction in inﬂammatory responses or more
speciﬁcally attenuated IL-6 release. Another mechanism
explaining the lower CRP concentrations in elderly patients
can be a diminished synthetic function of the liver due to
physiological ageing becoming apparent in acute inﬂammatory
conditions such as CAP. In this respect it should be noted that
in the absence of acute disease elderly patients tend to have
elevated CRP levels in their circulation [27,28], most likely due
to increased chronic diseases and other age-related processes
such as cumulative oxidative damage and a decline in sex
hormones [29]. To our knowledge, serum CRP concentrations
as a function of age have not been reported previously in
patients with CAP. In accordance with our data, one earlier
investigation reported a negative correlation between admis-
sion CRP levels and age in patients with bacteraemia caused by
Escherichia coli or S. pneumoniae [30].
The main limitations of this study are the small sample size
and baseline differences between groups, especially with
regard to co-morbidity, including COPD. In addition, the
analysis is based on clinically documented CAP cases; studies
focusing on microbiology-conﬁrmed cases might yield different
results. Moreover, the exact onset of the disease could not be
measured and differences in clinical presentation between
young and elderly patients could have resulted in differential
time periods between infection and hospital admission. As
such, our study can be confounded by the possibility that
different stages of the immune response to CAP were studied
in young and elderly patients. Finally, our investigation does
not establish whether old patients have longer length of
hospital stay and increased mortality as a consequence of CAP
or as a consequence of exacerbation of chronic pre-existing
diseases due to CAP.
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In conclusion, our results indicate that elderly patients with
CAP show an absolute (serum CRP) or relative (serum
cytokines) reduction in their systemic inﬂammatory response
on admission and during the course of their hospitalization.
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